This week, the ASCRS assesses implications of the Cypass microstent withdrawal, Today show co-anchor Craig Melvin describes his corneal ulcer diagnosis and an experimental gene therapy for X-linked retinitis pigmentosa begins trials in the United States. Source: AAO
Regulatory officials have approved Xelpros 0.005%, a first-line treatment for open-angle glaucoma and ocular hypertension that lacks the preservative benzalkonium chloride. Source: AAO
In this retrospective analysis, the authors examined corneal transplant survival rates based on patients’ primary corneal diagnosis and type of regraft surgery. Source: AAO
In this retrospective study, researchers characterized the pediatric acute ocular injuries reported to emergency departments in the United States. Source: AAO
This large multinational retrospective analysis examined host and pathogen factors that were predictive of keratoconjunctivitis outcomes. Source: AAO
In this retrospective study, researchers compared the prognostic accuracy of gene expression profiling with tumor-node-metastasis (TNM) staging for uveal melanoma. Source: AAO
This week, a malaria drug finds new purpose as a treatment for retinal neovascularization, a new tool stimulates and monitors retinal neuron activity and human stem cells soothe chemical eye burns. Source: AAO
In this retrospective review, investigators evaluated the improvement in ocular alignment among patients who underwent horizontal strabismus surgery with Tenon’s recession for thyroid eye disease (TED). Source: AAO
This study evaluated the effects of a single suprachoroidal injection of a proprietary triamcinolone acetonide suspension (CLS-TA) in patients with macular edema due to noninfectious uveitis. Source: AAO
This study gauged the risk of anterior segment complications after vaccination with the live herpes zoster virus. Source: AAO